Wikidata

(Q125889752)

English

A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy

scientific article published in 2022

In more languages

Statements

title
A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy (English)
1 reference
stated in
Crossref
DOI
10.7150/thno.75037
reference URL
https://api.crossref.org/v1/works/https://doi.org/10.7150/thno.75037
retrieved
12 May 2024
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q125889752&oldid=2186791396"